Radium-223 plus abiraterone in metastatic castration-resistant prostate cancer: a cautionary tale

Transl Androl Urol. 2019 Jul;8(Suppl 3):S341-S345. doi: 10.21037/tau.2019.05.02.

Authors

Ramy Sedhom¹, Emmanuel S Antonarakis¹

Affiliation

¹ Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.

No abstract available

Publication types

Editorial
Comment

Grants and funding